In recent years, due to the continuous favorable policies and the continuous expansion of market demand, as well as the continuous enhancement of the independent innovation capability of a large number of domestic medical device enterprises, China's medical device industry has developed rapidly, and has gradually broken the monopoly of foreign products in China's medical device market. situation. At the same time, the momentum of internationalization of the medical device industry is also very strong. A number of outstanding brands are embarking on the international high-end medical device market stage and are sought after by the international market. Among them, Mindray Medical is representative. Under the increasingly competitive international competition environment of globalization, China's medical device companies are faced with the development direction and strategic choices. How to improve the international competitiveness of China's medical device companies, how to strive for market share according to their own development needs, and make a smooth overseas entry. The competitive strategy of the market, the promotion of the brand image, and the strong vitality of the company are the problems that many medical device companies need to think about now. The potential stock of the New Third Board, Camm Medical, responded to the above problems with practical actions.
Not long ago, the news about the successful acquisition of Shenzhen Anjian by Kam Medical and the first cross-border merger of the New Third Board quickly became the focus of the industry and was reported. Xiao Bian understands that Came Medical's multiple asset restructuring initiatives are mainly to help companies improve their overall strength and competitiveness and achieve long-term development requirements.
According to industry analysts, since the adoption of the relevant proposal to subscribe for Korea's GEMSS, Camm Medical quickly opened up the overseas market, achieving global simultaneous research and development, simultaneous manufacturing and synchronization services, which is in line with the long-term goal of Camm Medical's global layout.
According to the analysis, “Guangdong GEMSS has established more than a dozen world-class technology R&D centers in Tokyo, Japan, Seoul, South Korea, Hanoi, New York, Beijing, Shanghai, Shenzhen, Nanjing, Bangkok, Indonesia, Jakarta, and Brussels, Belgium. The office is a professional comprehensive supply organization covering the development of multidisciplinary medical technology . The market prospects of the products involved are very broad. Toshiba is also one of the shareholders of GEMSS. Toshiba has participated in the design and development of GEMSS main products. After this round of mergers and acquisitions, the overall technical level of Camm Medical will be greatly improved, which is undoubtedly gratifying for domestic medical equipment companies. The perfect overseas layout of GEMSS and the broad market are all with good profit expectations. ."
In the process of negotiating with several authoritative financial weekly magazines, Xiaobian also pointed out that Camm Medical's acquisition of GEMSS has another important reason: the two are highly consistent in product and corporate culture. After the integration of resources, the Camm medical product line is more abundant and reasonable. The two have a strong consensus on cooperation. They all pay great attention to talents and scientific research and innovation. Because they are engaged in human life and health, they must have strong social responsibilities. With the heart and professionalism, GEMSS's participation can not only enhance the overall strength of Camm Medical, but also inject a new force into the Chinese market to promote the development of local medical device companies. â€
Then, after the successful acquisition of South Korea's GEMSS company, is Came Medical's rumor that “GEMSS company has suffered losses for three consecutive years, which will be detrimental to the operation of Camm Medical�
Through many negotiations with the relevant staff of Kam Medical, I learned that instead of worrying about the loss of GEMSS, there are many reasons for the loss, and the problem can not be partial. They are interested in GEMSS' excellent R&D technology, good market reputation, perfect overseas layout and broad market prospects. The most important thing for a medical device company is the complete qualification and the perfect layout. It is necessary to continuously innovate and change for the longer-term development of the company. Today is an era of cooperation and win-win. Camm Healthcare is confident that it can work together with GEMSS to seek greater development. It is hoped that investors can take a more comprehensive and long-term view of the development of this merger and subsequent Cam Medical.
Professional venture capitalists in the industry also analyzed: “The Korean medical device development environment is different from that in China, especially in terms of cost. Korea’s cost pressure is mainly reflected in the labor and land cost. According to the survey of the Korea Economic People’s Federation. It shows that compared with China, the industrial park in South Korea is 10 times more labor cost than China, and the land price is nearly 40 times higher. According to the Korean “Korean Daily†analysis, the average monthly income of production workers in the Qingdao Development Zone of Shandong Province, China. It is within the range of 7~112,000 won. On the contrary, the average income of South Korea's Half Moon and Shihua Industrial Park is more than 1 million won. In the price of the factory to obtain the price, Qingdao is 488.1 million won per ping, and the semi-monthly and initial chemical industrial park It is about 2 million won. It can be seen that the cost pressure of Korean companies is very large. The demand for talents in the medical device field is more demanding. Coupled with the huge cost of R&D and experimentation, more and more companies are beginning to make ends meet, requiring these companies to Transform as soon as possible and seek more development opportunities."
In addition, in terms of taxes, South Korea is twice as high as China. Through the above comparison of the industrial parks in Korea and China, it is possible to understand why Korean companies are going overseas. After a deep understanding of the Korean company GEMSS, Xiaobian also discovered the "secret" behind its loss. In order to cope with the high cost of domestic human land and the active development of overseas markets, GEMSS has been building factories in developing countries with large labor force such as Vietnam, Thailand and India in the past three years, which can improve the cost problem and build overseas factories. In the early stage, it required a large amount of financial support, but it also helped GEMSS to quickly establish a sales network overseas. To a certain extent, it also facilitated the return of funds. GEMSS sacrificed short-term benefits in order to achieve longer-term goals. Nowadays, the overseas factories have been basically completed, and the global layout is basically perfect. In addition, Xiao Bian also learned that GEMSS has paid great attention to quality product research and development and hardware equipment. The annual investment in scientific research is not enough for many medical equipment companies. All of the company's equipment is basically automated machines from Japan and Germany, which can save a lot of manpower in Korea in the past, and the company's operating costs will be greatly reduced in the long run.
Through communication with employees of Camm Medical, they have already hired a third-party authority, including the United States and South Korea, to conduct a detailed investigation of GEMSS for a long time before the merger, and to do the research for the company. After a series of analysis and evaluation, I got a deep understanding of GEMSS, and after careful consideration, I dropped the olive branch to the company.
Now we can also understand why Came Medical and Korea's GEMSS companies have been able to handle this century so smoothly. Of course, GEMSS is also taking advantage of Cam's medical strength, including capital and operational capabilities. Came Medical has strong support from China-Belgium investment institutions (China-Belgium Fund). The cooperation between the two is very tacit. M.Med's multiple M&A initiatives are very supportive. It shows that China and the United States are far-sighted and the long-term vision of Came Medical's management is also very important for investors in the New Third Board.
Especially worth mentioning is that the editor of the New Third Board section added: "Since 2015, Camm Medical has opened more than 20 offices across the country, vigorously explored channel resources, greatly improved procurement, and improved services. The architecture system. This forward-looking initiative, combined with the resources of GEMSS, combined with the existing advantages of CamMed, the volume of orders has surged and the profit margin has also increased. The price space has greatly reduced the cost. In this way, the cost and profit that the outside world is worried about is exactly what Camm Medical is not worried about.
Today's new three board opportunities and challenges coexist. The new listed companies are mostly high-tech enterprises, and the listing time is short and the procedures are simple. Therefore, since the national stock transfer system accepted the listed enterprises on December 31, 2013, the number of listed companies in the New Third Board has grown rapidly. By 2015, The NEEQ has made rapid progress in the number of listed companies, financing, mergers and acquisitions, transactions, etc., and the policy dividends that promote its rapid development have also been released. In the foreseeable future, with the implementation of the investment threshold, the implementation of the tiered management, the launch of the bidding mechanism, and the implementation of institutional reforms such as the GEM and the GEM, the NEE will usher in greater development opportunities.
As a piece of land, the New Third Board has attracted a large number of investors to compete in, and some malicious smashing phenomenon has begun to appear. Xiaobian has received the response of many companies in the New Third Board. On the eve of the resumption of trading, there has been no Less false or malicious reports against the company have caused a lot of damage to the image of the company. What is even more surprising is that these companies have received an investor before and after the report of malicious and smashed reports. Or a low-cost acquisition of "advice" by an investment institution, Xiao Bian can not help but doubt the purpose of these people and the organization behind it. At the same time, many of the friends in the Oriental Fortune Network New Third Board also reminded the new three board companies to beware of such behaviors, absolutely can not be compromised, together with actual actions to resist this malicious smashing, attempting to buy high-priced shots at low prices. Bad behavior, but also the pure land of a healthy development of the New Third Board.
Dental Nitrile Gloves,Nitrile Gloves Large,Eu Medical Dental Gloves,Gloves Nitrile Disposable Gloves
Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshimedical.com